The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic Studies
Abstract
Lipoproteins are a major risk factor for atherosclerotic cardiovascular diseases (ASCVD). Among the lipoproteins, low-density lipoproteins (LDL) have been shown to be causally associated with ASCVD development. In contrast, triglycerides or triglyceride-rich lipoproteins receive less attention than LDL because there is little definite evidence from randomized controlled trials. A Mendelian randomization study has recently been published in which a causal association could be estimated with observational datasets. Using such Mendelian randomization studies, ranging from common to rare genetic variations, triglycerides seem to be causally associated with ASCVD outcomes independent of LDL. Although the “causal association” of serum triglycerides and ASCVD is difficult to assert, accumulated evidence from clinical and Mendelian randomization studies, using common and rare genetic variations, strongly supports such an association. In this article, we provide a summary of investigations focusing on important causal associations between serum triglycerides and ASCVD from the clinical point of view.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Blood lipid levels (especially low-density lipoprotein cholesterol (LDL cholesterol) and triglycerides) and blood pressure (BP) represent important determinants of cardiovascular health [26, 27].”
From Nutritional Status and Cardiovascular Health in Female Adolescent Elite-Level Artistic Gymnasts and Swimmers: A Cross-Sectional Study of 31 Athletes (2021) · cites this paper as [27]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Sabatine, M. S., Giugliano, R. P., Keech, A. C., Honarpour, N., Wiviott, S. D., Murphy, S. A., Kuder, J. F., Wang, H., Liu, T., Wasserman, S. M., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1615664 · Cited by 6,138
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Cannon, C. P., Blazing, M. A., Giugliano, R. P., McCagg, A., White, J. A., Theroux, P., Darius, H., Lewis, B. S., Ophuis, T. O., Jukema, J. W., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410489 · Cited by 4,487
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001282 · Cited by 2,837
Triglycerides and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Miller, M., Stone, N. J., Ballantyne, C., Bittner, V., Criqui, M. H., Ginsberg, H. N., Goldberg, A. C., Howard, W. J., Jacobson, M. S., Kris-Etherton, P. M., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182160726 · Cited by 1,871
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Bansal, S., Buring, J. E., Rifai, N., Mora, S., Sacks, F. M., & Ridker, P. M. (2007) · JAMA · doi:10.1001/jama.298.3.309 · Cited by 1,619
Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
The TG and HDL Working Group of the Exome Sequencing Project, N. H. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1307095 · Cited by 1,071
Common variants associated with plasma triglycerides and risk for coronary artery disease
Do, R., Willer, C. J., Schmidt, E. M., Sengupta, S., Gao, C., Peloso, G. M., Gustafsson, S., Kanoni, S., Ganna, A., Chen, J., et al. (2013) · Nature Genetics · doi:10.1038/ng.2795 · Cited by 862
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction
Do, R., Stitziel, N. O., Won, H.-H., Jørgensen, A. B., Duga, S., Angelica Merlini, P., Kiezun, A., Farrall, M., Goel, A., Zuk, O., et al. (2015) · Nature · doi:10.1038/nature13917 · Cited by 650
Nonfasting triglycerides and risk of ischemic stroke in the general population
Freiberg, J. J. (2008) · JAMA · doi:10.1001/jama.2008.621 · Cited by 542
Research works printed but not linked: 28
- Trialists, 2010, Efficacy and safety of more intensive lowering of LDL cholesterol: A meta-analysis of data from 170,000 participants in 26 randomised trials, Lancet, 376, 1670, 10.1016/S0140-6736(10)61350-5 · DOI · Paper page
- Varbo, 2016, Remnant cholesterol and triglyceride-rich lipoproteins in atherosclerosis progression and cardiovascular disease, Arterioscler. Thromb. Vasc. Biol., 36, 2133, 10.1161/ATVBAHA.116.308305 · DOI
- Tada, 2018, Serum triglycerides predict first cardiovascular events in diabetic patients with hypercholesterolemia and retinopathy, Eur. J. Prev. Cardiol., 25, 1852, 10.1177/2047487318796989 · DOI
- Madsen, 2018, Unmet need for primary prevention in individuals with hypertriglyceridaemia not eligible for statin therapy according to European Society of Cardiology/European Atherosclerosis Society guidelines: A contemporary population-based study, Eur. Heart J., 39, 610, 10.1093/eurheartj/ehx659 · DOI · Paper page
- Lampe, 1983, Human stratum corneum lipids: Characterization and regional variations, J. Lipid Res., 24, 120, 10.1016/S0022-2275(20)38005-6 · DOI · Paper page
- Proctor, 2003, Intimal retention of cholesterol derived from apolipoprotein B100- and apolipoprotein B48-containing lipoproteins in carotid arteries of Watanabe heritable hyperlipidemic rabbits, Arterioscler. Thromb. Vasc. Biol., 23, 1595, 10.1161/01.ATV.0000084638.14534.0A · DOI
- Chung, 1989, Lipolytic surface remnants of triglyceride-rich lipoproteins are cytotoxic to macrophages but not in the presence of high density lipoprotein. A possible mechanism of atherogenesis?, J. Clin. Investig., 83, 1363, 10.1172/JCI114024 · DOI
- Tomono, 1994, Uptake of remnant like particles (RLP) in diabetic patients from mouse peritoneal macrophages, J. Atheroscler. Thromb., 1, 98, 10.5551/jat1994.1.98 · DOI
- Tada, 2018, Remnant-like particles and coronary artery disease in familial hypercholesterolemia, Clin. Chim. Acta, 482, 120, 10.1016/j.cca.2018.04.007 · DOI
- Tada, 2017, Comprehensive genotyping in dyslipidemia: Mendelian dyslipidemias caused by rare variants and Mendelian randomization studies using common variants, J. Hum. Genet., 62, 453, 10.1038/jhg.2016.159 · DOI
- Liu, 2017, Exome-wide association study of plasma lipids in >300,000 individuals, Nat. Genet., 49, 1758, 10.1038/ng.3977 · DOI · Paper page
- Tada, 2018, Genetic variations, triglycerides, and atherosclerotic disease, J. Atheroscler. Thromb., 19, 31
- Tada, 2015, Clinical characteristics of Japanese patients with severe hypertriglyceridemia, J. Clin. Lipidol., 9, 519, 10.1016/j.jacl.2015.05.004 · DOI
- Teramoto, 2018, Molecular and functional characterization of familial chylomicronemia syndrome, Atherosclerosis, 269, 272, 10.1016/j.atherosclerosis.2017.11.006 · DOI
- Appel, 2005, Effects of protein, monounsaturated fat, and carbohydrate intake on blood pressure and serum lipids: Results of the OmniHeart randomized trial, JAMA, 294, 2455, 10.1001/jama.294.19.2455 · DOI · Paper page
- Bezafibrate Infarction Prevention (BIP) Study (2000). Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease. Circulation, 102, 21–27. · DOI · Paper page
- Rubins, 2002, Diabetes, plasma insulin, and cardiovascular disease: Subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT), Arch. Intern. Med., 162, 2597, 10.1001/archinte.162.22.2597 · DOI · Paper page
- Sullivan, 2011, Associations between the use of metformin, sulphonylureas, or diet alone and cardiovascular outcomes in 6005 people with type 2 diabetes in the FIELD study, Diabetes Res. Clin. Pract., 94, 284, 10.1016/j.diabres.2011.07.028 · DOI
- Diabetes Atherosclerosis Intervention Study Investigators (2001). Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: The Diabetes Atherosclerosis Intervention Study, a randomised study. Lancet, 357, 905–910. · DOI · Paper page
- Abdelhamid, 2018, Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease, Cochrane Database Syst. Rev., 7, CD012345
- Martin, 2013, Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile, JAMA, 310, 2061, 10.1001/jama.2013.280532 · DOI · Paper page
- Sever, 2003, Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (Ascot-LLA): A multicentre randomised controlled trial, Lancet, 361, 1149, 10.1016/S0140-6736(03)12948-0 · DOI · Paper page
- SEARCH Study Collaborative Group, Bowman, L., Armitage, J., Bulbulia, R., Parish, S., and Collins, R. (2007). Study of the effectiveness of additional reductions in cholesterol and homocysteine (SEARCH): Characteristics of a randomized trial among 12064 myocardial infarction survivors. Am. Heart J., 154, 815–823. · DOI
- Stone, 2014, 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines, J. Am. Coll. Cardiol., 63, 2889, 10.1016/j.jacc.2013.11.002 · DOI · Paper page
- Tada, 2012, Post-prandial remnant lipoprotein metabolism in autosomal recessive hypercholesterolaemia, Eur. J. Clin. Investig., 42, 1094, 10.1111/j.1365-2362.2012.02700.x · DOI
- Tada, H., Nomura, A., Nohara, A., Inazu, A., Mabuchi, H., Yamagishi, M., and Kawashiri, M.A. (2018). Post-prandial Remnant Lipoprotein Metabolism in Sitosterolemia. J. Atheroscler. Thromb. · DOI
- Reith, 2016, Management of residual risk after statin therapy, Atherosclerosis, 245, 161, 10.1016/j.atherosclerosis.2015.12.018 · DOI
- Sato, 2016, The majority of lipoprotein lipase in plasma is bound to remnant lipoproteins: A new definition of remnant lipoproteins, Clin. Chim. Acta, 461, 114, 10.1016/j.cca.2016.06.020 · DOI
Cited by
Jakše, B., Jakše, B., Mis, N. F., Jug, B., Šajber, D., Godnov, U., & Čuk, I. (2021) · Journal of Nutrition and Metabolism · doi:10.1155/2021/8810548 · Cited by 21
Metadata
- Authors
- Tada, H., Nohara, A., & Kawashiri, M.-A.
- Venue
- Nutrients
- Publisher
- MDPI AG
- Published
- 2018-11-17
- Volume
- 10
- Issue
- 11
- Pages
- 1789
- ISSN
- 2072-6643
- Cited by
- 45
- References
- 17
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic Studies. https://app.cochat.ai/papers/10.3390/nu10111789
- The paper
- Tada, H., Nohara, A., & Kawashiri, M.-A. (2018). Serum Triglycerides and Atherosclerotic Cardiovascular Disease: Insights from Clinical and Genetic Studies. Nutrients. https://doi.org/10.3390/nu10111789
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.